Summary
GlobalData, the industry analysis specialist's new report, "Cancer Vaccines-Pipeline Analysis and Market Forecasts to 2016" is an essential source of information and analysis on the global cancer vaccines market. The report identifies the key trends shaping and driving the global cancer vaccines market. The report also provides insight on the prevalent competitive landscape and the emerging players expected to bring significant shift in the market positioning of the existing market leaders. Most importantly, the report provides valuable insight on the pipeline products within the global cancer vaccines sector.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in house analysis by GlobalData's team of industry experts.

Scope
The scope of the report includes:
-Annualized global cancer vaccines market revenues data from 2000 to 2009, forecast forward for 7 years to 2016.
-Geographic markets covered in this report include the US, the UK, Italy, Spain, Germany, France, and Japan.
-Pipeline analysis data providing a split across different phases, mechanism of action being developed and emerging trends.
-Analysis of the current and future market competition in the global cancer vaccines market.
-Insightful review of the key industry drivers, restraints and challenges. Each trend is independently researched to provide qualitative analysis of its implications.
-Key topics covered include strategic competitor assessment, market characterization, unmet needs and implications for future market associated with cancer vaccines.

Reasons to buy
The report will enhance your decision making capability in a more rapid and time sensitive manner. It will allow you to:
-Develop and design your in-licensing and out-licensing strategies through review of pipeline products and technologies and by identifying companies with the most robust pipeline.
-Develop business strategies by understanding the trends shaping and driving the global cancer vaccines market.
-Drive revenues by understanding key trends, innovative products and technologies, market segments and companies likely to impact the global cancer vaccines market in future.
-Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the performance of various competitors.
-Identify emerging players with potentially strong product portfolio and create effective   counter-strategies to gain competitive advantage.
-Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.
-What's the next big thing in the global cancer vaccines market landscape? -Identify, understand and capitalize.

Table of Contents
1 Table of contents 3
1.1 List of Tables 5
1.2 List of Figures 5
2 Global Cancer Vaccines Market: Market Characterizations 6
2.1 Overview 6
2.2 Global Cancer Vaccines Market Size 6
2.3 Global Cancer Vaccines Market Forecast and CAGR 7
2.4 Drivers and Barriers for the Global Cancer Vaccines Market 7
2.4.1 Drivers for the Global Cancer Vaccines Market 7
2.4.2 Barriers for the Global Cancer Vaccines Market 8
2.5 Opportunity and Unmet Need 8
2.6 Key Takeaway 9
3 Cancer Vaccines Market: Competitive Assessment 10
3.1 Overview 10
3.2 Strategic Competitor Assessment 10
3.3 Product Profile for the Marketed Vaccines in the Cancer Market 10
3.3.1 Gardasil 10
3.3.2 Cervarix 12
3.3.3 Oncophage (vitespen) 13
3.4 Key Takeaway 14
4 Cancer Vaccines Market: Pipeline Assessment 15
4.1 Overview 15
4.2 Strategic Pipeline Assessment 15
4.2.1 Technology Trends Analytic Framework 15
4.3 Cancer Vaccines Pipeline-Promising Vaccines under Clinical Development 17
4.4 Molecule Profile for Promising Cancer Vaccines under Clinical Development 18
4.4.1 Provenge (sipuleucel-T) 18
4.4.2 Stimuvax 19
4.4.3 OncoVAX 20
4.4.4 MAGE-A3 ASCI 21
4.4.5 Oncovex (GM-CSF) 22
4.5 Global Cancer Vaccines Market-Clinical Pipeline by Vaccine Type 24
4.6 Global Cancer Vaccines Pipeline-Pipeline by Clinical Phases of Development 24
4.6.1 Cancer Vaccines-Regulatory Filing and Phase III Clinical Pipeline 25
4.6.2 Cancer Vaccines Market-Phase II Clinical Pipeline 26
4.6.3 Cervical Cancer Therapeutics-Phase I Clinical Pipeline 29
4.6.4 Cancer Vaccines-Preclinical Pipeline 34
4.6.5 Cancer Vaccines-Discovery Pipeline 34
4.7 Key Takeaway 34
5 Cancer Vaccines Market: Implications for Future Market Competition 35
6 Global Cancer Vaccines Market: Prominent Market Players 37
6.1 Introduction 37
6.2 Dendreon Corporation 37
6.2.1 Overview 37
6.2.2 Financial Performance 37
6.2.3 Business Description 38
6.2.4 Cancer Vaccines Product Portfolio 38
6.3 Vaccinogen Inc. 39
6.3.1 Overview 39
6.3.2 Cancer Vaccines Product Portfolio 40
6.4 GlaxoSmithKline Plc. 41
6.4.1 Overview 41
6.4.2 Oncology Portfolio 42
6.4.3 Cancer Vaccines Product Portfolio 43
7 Global Cancer Vaccines Market: Appendix 45
7.1 Market Definitions 45
7.2 Abbreviations 45
7.3 Research Methodology 46
7.3.1 Coverage 46
7.3.2 Secondary Research 47
7.3.3 Forecasting 47
7.3.4 Primary Research 49
7.3.5 Expert Panels Validation 50
7.4 Contact Us 50
7.5 Disclaimer 50
7.6 Sources 50

List of Tables
1.1 List of Tables
Table 1:  Cancer Vaccines Market, Global, Market Revenue ($bn), 2007-2016 7
Table 2:  Marketed Vaccines Comparison in the Cancer Vaccines Market, 2010 14
Table 3:  Cancer Vaccines Pipeline-Most Promising Vaccines under Clinical Development, 2010 17
Table 4: Global Cancer Vaccines Market-Regulatory Filling and Phase III Clinical Pipeline, January 2010 25
Table 5: Global Cancer Vaccines Market-Phase II Clinical Pipeline, January 2010 26
Table 6: Global Cancer Vaccines Market-Phase I Clinical Pipeline, January 2010 29
Table 7: Global Cancer Vaccines Market-Preclinical Pipeline, January 2010 34
Table 8: Global Cancer Vaccines Market-Discovery Pipeline, January 2010 34
Table 9:  Dendreon Corporation-Oncology Pipeline Products, January 2010 38
Table 10:   Vaccinogen Inc.-Oncology Pipeline Products, January 2010 40
Table 11:  GlaxoSmithKline Plc.-Oncology Pipeline Products, January 2010 42

List of Figures
1.2 List of Figures
Figure 1:  Cancer Vaccines Market, Global, Revenue Forecasts, 2007-2016 7
Figure 2:  Opportunity and Unmet Need in the Cancer Vaccines Market, 2010 8
Figure 3:  Strategic Competitor Assessment of the Vaccines in the Global Cancer Vaccines Market, 2010 10
Figure 4:  Technology Trends Analytic Framework of the Global Cancer Vaccines Phase II and Phase III Pipeline, January 2010 15
Figure 5:  Technology Trends Analytic Framework  of the Global Cancer Vaccines Phase II and Phase III Pipeline-Description, January 2010 16
Figure 6:  Global Cancer Vaccines Market-Clinical Pipeline by Vaccine Type, 2010 24
Figure 7:  Cancer Vaccines Pipeline by Phase of Clinical Development, January 2010 24
Figure 8:  Implications for Future Market Competition in the Cancer Vaccines Market, 2010 35
Figure 9:  Global Cancer Vaccines Therapeutics Market-Clinical Pipeline by Company, 2010 37
Figure 10:  GlobalData Methodology 46
Figure 11:  GlobalData  Market Forecasting Model 49